Sysmex America, Inc.
Sysmex Corporation is a global leader in healthcare and medical diagnostics, committed to advancing medical technology and improving patient care through innovative products, research, and sustainability initiatives. The company emphasizes corporate governance, environmental responsibility, and stakeholder engagement to maximize corporate value and contribute to society.
Industries
Nr. of Employees
large (251-1000)
Sysmex America, Inc.
1-5-1 Waki-hama Kaigan-dori, Chuo-ku, Kobe, Hyogo, Japan
Products
Automated hematology analyzers with integrated specimen handling
Systems for complete blood count and associated hematology testing designed for high-throughput clinical workflows with reduced footprint and power consumption.
Automated coagulation analyzers and associated reagents
Automated coagulation testing systems with reagents for clinical hemostasis assessment, developed for automated workflow and regulatory market entry.
Automated urinalysis and urine-formed element analyzers
Automated instruments for urine-sediment and formed-element analysis using particle measurement/flow cytometry techniques to support both primary screening and detailed sediment analysis.
Molecular diagnostic systems and cancer gene-panel profiling
Molecular assay platforms and test systems for genetic and epigenetic profiling of solid tumors to support therapeutic decision-making and clinical care pathways.
Immunoassay platforms and antigen/antibody reagent kits
Automated immunoassay analyzers and reagent kits enabling rapid, high-sensitivity measurement of protein biomarkers and infectious-disease antigens/antibodies.
Diagnostic reagents, concentrated formats and precision controls
A range of reagents and quality-control materials, including concentrated formulations designed to reduce packaging, transport footprint and per-test consumable usage.
Automated hematology analyzers with integrated specimen handling
Systems for complete blood count and associated hematology testing designed for high-throughput clinical workflows with reduced footprint and power consumption.
Automated coagulation analyzers and associated reagents
Automated coagulation testing systems with reagents for clinical hemostasis assessment, developed for automated workflow and regulatory market entry.
Automated urinalysis and urine-formed element analyzers
Automated instruments for urine-sediment and formed-element analysis using particle measurement/flow cytometry techniques to support both primary screening and detailed sediment analysis.
Molecular diagnostic systems and cancer gene-panel profiling
Molecular assay platforms and test systems for genetic and epigenetic profiling of solid tumors to support therapeutic decision-making and clinical care pathways.
Immunoassay platforms and antigen/antibody reagent kits
Automated immunoassay analyzers and reagent kits enabling rapid, high-sensitivity measurement of protein biomarkers and infectious-disease antigens/antibodies.
Diagnostic reagents, concentrated formats and precision controls
A range of reagents and quality-control materials, including concentrated formulations designed to reduce packaging, transport footprint and per-test consumable usage.
Services
Academic seminars, provision of scientific materials and consultation for clinicians and laboratory personnel; support for laboratory accreditation activities such as ISO15189.
Customer-facing inquiry and support services for diagnostic product application, plus networked external quality-assessment and data-exchange services to support laboratory workflow and quality control.
Onsite maintenance and technical field service combined with remote training and e-learning to maximize instrument availability and reduce travel-related resource use.
Research and development of biomarker and genetic assays and provision of contract testing/measurement services to support clinical validation and research projects.
Academic seminars, provision of scientific materials and consultation for clinicians and laboratory personnel; support for laboratory accreditation activities such as ISO15189.
Customer-facing inquiry and support services for diagnostic product application, plus networked external quality-assessment and data-exchange services to support laboratory workflow and quality control.
Onsite maintenance and technical field service combined with remote training and e-learning to maximize instrument availability and reduce travel-related resource use.
Research and development of biomarker and genetic assays and provision of contract testing/measurement services to support clinical validation and research projects.
Expertise Areas
- Automated hematology and laboratory automation
- Coagulation testing and hemostasis diagnostics
- Urinalysis using particle measurement and flow cytometry
- Molecular diagnostics and cancer gene-panel testing
Key Technologies
- Automated hematology instrumentation
- Automated coagulation analyzers
- Flow cytometry / particle-based urine analyzers
- Chemiluminescent enzyme immunoassay (CLEIA)
News & Updates
A joint research course is established to elucidate the pathology and develop new diagnostic technologies for neurodevelopmental and degenerative diseases.
The fully automated blood coagulation measurement device CN™-6000 has received clearance from the US FDA for pre-market notification.
A new manufacturing subsidiary factory has been completed and started shipment, strengthening the group's production system for stable supply and productivity.
The kit contributes to appropriate treatment decisions for colon and rectal cancer.
Sysmex's 50 Years of History
A detailed history of Sysmex's development and milestones over 50 years.
Selected for Dow Jones Sustainability World Index for 8 Consecutive Years
Sysmex has been recognized for its sustainability efforts by being included in the Dow Jones Sustainability World Index for eight consecutive years.
A joint research course is established to elucidate the pathology and develop new diagnostic technologies for neurodevelopmental and degenerative diseases.
The fully automated blood coagulation measurement device CN™-6000 has received clearance from the US FDA for pre-market notification.
A new manufacturing subsidiary factory has been completed and started shipment, strengthening the group's production system for stable supply and productivity.
The kit contributes to appropriate treatment decisions for colon and rectal cancer.
Sysmex's 50 Years of History
A detailed history of Sysmex's development and milestones over 50 years.
Selected for Dow Jones Sustainability World Index for 8 Consecutive Years
Sysmex has been recognized for its sustainability efforts by being included in the Dow Jones Sustainability World Index for eight consecutive years.